Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,341 total articles
Guardant Health director Tariq Musa sold 116 shares of common stock on April 16, 2026, for $84.83 per share, totaling $9,840. A Form 4 filing also shows Musa exercised options on 250 shares of Restricted Stock Units at a price of $0 on April 15. After these moves he directly holds 8,528 shares. The insider transactions come amid recent company fina…
Slide Insurance Holdings Chief Executive Bruce Lucas sold 190,836 shares of common stock on April 14, 2026 under a pre-arranged 10b5-1 trading plan, generating about $3.4 million. The transaction and related family sale come amid robust fourth-quarter results and an active share repurchase program, while analyses show the stock may be undervalued a…
Shannon Lucas, president and COO of Slide Insurance Holdings Inc (SLDE), sold 18,874 shares on April 14, 2026 under a 10b5-1 plan, generating $340,486. The company recently reported robust fourth-quarter 2025 results, completed a $120 million buyback and authorized a new $125 million program, while several brokers maintained or raised ratings.
Paul V. Woolway, Managing Director and Chief Banking Officer at Charles Schwab, exercised options for 15,883 shares and sold the same number of shares on April 14-15, 2026 under a pre-arranged 10b5-1 plan, generating $1,572,478. The transactions followed option exercises costing $826,710 and leave Woolway with a mix of direct and indirect holdings.…
Adaptive Biotechnologies Corp (NASDAQ: ADPT) President and COO Julie Rubinstein sold 57,180 shares between April 14 and April 16, 2026, for roughly $826,251 and concurrently exercised options for 44,166 shares at $8.46 each. The trades were part of a pre-arranged Rule 10b5-1 plan adopted on November 18, 2025. Adaptive reported stronger-than-expecte…
Mohit Kaushal, a director at The Oncology Institute, Inc. (NASDAQ: TOI), sold 95,719 shares across two transactions on April 14 and April 16, 2026, under a Rule 10b5-1 plan adopted in December 2025. The combined proceeds were $335,133, and Kaushal’s direct holdings decreased to 172,583 shares following the sales. The stock has risen sharply over th…
Michael Jon Brown, Executive Vice President and Chief Legal Officer of Dexcom, sold 1,700 shares on April 15, 2026 for $63.04 per share, generating $107,168. The sale was executed under a 10b5-1 trading plan adopted on November 26, 2025. Brown’s remaining direct holdings total 111,204 shares, which include 77,603 unvested restricted stock units wit…
American Heritage Railways, a 10% holder of Rocky Mountain Chocolate Factory, sold 54,100 shares between February 19 and March 5, 2026, at prices between $2.60 and $2.619, raising about $140,833. The stock currently trades at $2.28, below the sale prices. Separately, Rocky Mountain Chocolate Factory is initiating an omnichannel growth strategy, inc…
Marvell Technology CFO Willem A. Meintjes disposed of 30,000 shares on April 15, 2026, in a transaction that generated roughly $4.02 million as the stock traded close to its 52-week peak. The sales were carried out under a 10b5-1 plan adopted earlier this year. Concurrently, Meintjes received large grants of restricted and performance stock units a…
Laura Oliphant, a director at Aehr Test Systems, sold 4,665 shares on April 16, 2026, for $399,267. The transaction occurred while the stock has risen sharply over the past year but currently trades below the sale price. Aehr also announced a record $41 million production order from a hyperscale customer for package-level burn-in of custom AI proce…
Director Peter A. Thompson sold 510,683 shares of Sionna Therapeutics (NASDAQ:SION) between April 14 and April 16, 2026, in transactions totaling $22,945,043. The sales were executed under a pre-arranged 10b5-1 trading plan. Thompson still indirectly holds 3,020,119 shares through OrbiMed Private Investments VIII, LP. The stock trades near its 52-w…
Photronics Inc. (NASDAQ: PLAB) saw a senior operations executive, Wang Hsueh-Chun, sell 19,250 shares on April 14, 2026, in transactions totaling $872,025. The company reported fiscal Q1 2026 results that beat expectations on both earnings and revenue, announced installation of a new mask writer at its Korea facility planned for fiscal Q2 2026, and…
Director Rhea J. Posedel sold 15,000 shares of Aehr Test Systems on April 16, 2026, generating roughly $1.21 million. The transaction takes place while the stock trades near $80.85 after an 891% rise over the past year. The company disclosed a $41 million production order for package-level burn-in of custom AI processor ASICs, reported mixed Q3 202…
Michael D. Cordano, Executive Vice President, Worldwide Sales at Micron Technology, disposed of 3,407 shares on April 14, 2026, at $435.00 per share, a transaction valued at $1.48 million. After the sale, Cordano retains direct ownership of 44,059 shares. The move occurs against a backdrop of a 561% year-over-year share-price surge and a market cap…
Chantelle Yvette Breithaupt, Senior Vice President and Chief Financial Officer of Arista Networks, sold 8,890 shares on April 14, 2026 under a pre-arranged 10b5-1 plan, realizing $1.37 million. The transaction leaves her with 60,734 shares. Separately, several analysts revised ratings and targets for Arista, citing stronger-than-expected quarterly …
Bloom Energy COO Satish Chitoori sold 20,000 shares of Class A common stock on April 14, 2026, for $204.23 per share, generating roughly $4.08 million and leaving him with 212,365 shares. The sale was carried out under a Rule 10b5-1 trading plan established Nov. 28, 2025. Separately, Bloom Energy and Oracle expanded a supply agreement from 1.2 GW t…
OrbiMed Advisors LLC, acting as a director of Sionna Therapeutics Inc (NASDAQ: SION), sold a total of 510,783 shares in three transactions between April 14 and April 16, 2026, generating $22,945,043 in proceeds. After the trades, the OrbiMed-related vehicle retains an indirect stake of 3,020,119 shares. The divestitures were carried out under a 10b…
Shawn Marie Soderberg, Bloom Energy's Chief Legal Officer and Corporate Secretary, sold 55,000 Class A shares on April 14-15, 2026, under a pre-arranged Rule 10b5-1 plan. The trades totaled $11,755,150. The transactions occur as Bloom Energy's shares trade near a 52-week high and after the company expanded an Oracle supply agreement that included w…
Astera Labs Chief Executive Officer Jitendra Mohan executed planned sales of company stock on April 15, 2026, generating roughly $518,036 in proceeds. The transactions were completed under a pre-arranged 10b5-1 plan and occurred while ALAB shares have risen substantially over the past year. Separately, the company reported a fourth-quarter 2025 ear…
Forager Fund, L.P., a roughly 10% shareholder in Regional Management Corp (RM), sold 37,827 shares of common stock in three transactions between April 14 and April 16, 2026, netting about $1.44 million. The Form 4 filing details the per-trade quantities, weighted average prices and price ranges. After the sales, Forager retains 981,436 shares.
Conor Kilroy, Chief Legal Officer and Secretary of Aura Biosciences, sold 11,738 shares on April 16, 2026, at prices between $7.02 and $7.05 for about $82,400. The sale, reported on a Form 4, was made to satisfy tax withholding obligations tied to vested restricted stock units and was automatic rather than a discretionary decision. Aura's shares ha…
Director Rajaram Gokul sold 2,100 shares of Pinterest Inc. Class A common stock on April 15, 2026, for $20.00 per share, netting $42,000. The sale was carried out under a Rule 10b5-1 trading plan adopted November 25, 2025. Pinterest is trading near a 52-week low and has attracted a range of analyst reactions and a $1 billion convertible note invest…
Johanna Mercier, Gilead Sciences' Chief Communications and Corporate Affairs Officer, disposed of 3,000 shares of company stock on April 15, 2026, for $140.96 per share, producing proceeds of $422,880. The transaction, carried out under a Rule 10b5-1 trading arrangement adopted on February 20, 2025, leaves Mercier with 128,779 shares directly held.…
Gilead Sciences Chief Financial Officer Andrew D. Dickinson sold 3,000 shares on April 15, 2026, at $140.96 per share, generating $422,880. The transaction was carried out under a Rule 10b5-1 trading plan adopted in August 2024. Gilead's shares are trading near $138.49 and have returned 36% over the past year. The company is pursuing expanded acces…
Kymera Therapeutics Chief Business Officer Noah Goodman sold 1,347 shares on April 14, 2026, at $90.00 per share for a total of $121,230 under a Rule 10b5-1 trading plan. The transaction leaves Goodman with direct ownership of 50,195.438 shares. The company is trading at $86.14 after a 244% year-over-year gain, and InvestingPro notes KYMR appears o…
